MedTrace Logo

Transcriptomic Evaluation of Endometrial Receptivity

NCT04141085 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2023-05-03

No results posted yet for this study

Summary

The purpose of this study is to comprehensively evaluate the transcriptomic signal of the endometrium before, during, and after the window of receptivity.

Conditions

  • Infertility, Female

Interventions

OTHER

Endometrial biopsy

All groups will undergo a mock frozen embryo transfer cycle with an endometrial biopsy being performed as opposed to an embryo transfer

Sponsors & Collaborators

  • Reproductive Medicine Associates of New Jersey

    lead OTHER

Principal Investigators

  • Richard T Scott, MD · Reproductive Medicine Associates of New Jersey

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-28
Primary Completion
2022-01-31
Completion
2022-12-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04141085 on ClinicalTrials.gov